TANG Capital Partners L.P., 10% Owner at Aptevo Therapeutics Inc. (APVO), bought 2,393,350 shares at $10.63 ($42.3M) on 2020-11-04, disclosed to the SEC on 2020-11-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.63 | 68,296 | $726K | 1.7% |
| 2 | $10.63 | 68,296 | $726K | 1.7% |
| 3 | $13.11 | 88,379 | $1.2M | 2.7% |
| 4 | $13.11 | 88,379 | $1.2M | 2.7% |
| 5 | $13.65 | 99,854 | $1.4M | 3.2% |
| 6 | $13.65 | 99,854 |
| $1.4M |
| 3.2% |
| 7 | $13.83 | 160,000 | $2.2M | 5.2% |
| 8 | $16.33 | 60,146 | $982K | 2.3% |
| 9 | $16.33 | 60,146 | $982K | 2.3% |
| 10 | $16.84 | 160,000 | $2.7M | 6.4% |
| 11 | $14.22 | 77,133 | $1.1M | 2.6% |
| 12 | $14.22 | 77,133 | $1.1M | 2.6% |
| 13 | $15.31 | 160,000 | $2.4M | 5.8% |
| 14 | $15.32 | 71,241 | $1.1M | 2.6% |
| 15 | $15.32 | 71,241 | $1.1M | 2.6% |
| 16 | $20.78 | 137,241 | $2.9M | 6.7% |
| 17 | $20.78 | 137,241 | $2.9M | 6.7% |
| 18 | $20.94 | 8,482 | $178K | 0.4% |
| 19 | $20.94 | 8,482 | $178K | 0.4% |
| 20 | $23.79 | 171,626 | $4.1M | 9.6% |
| 21 | $23.79 | 171,626 | $4.1M | 9.6% |
| 22 | $20.63 | 34,044 | $702K | 1.7% |
| 23 | $20.63 | 34,044 | $702K | 1.7% |
| 24 | $22.33 | 29,682 | $663K | 1.6% |
| 25 | $22.33 | 29,682 | $663K | 1.6% |
| 26 | $23.48 | 107,901 | $2.5M | 6.0% |
| 27 | $23.48 | 107,901 | $2.5M | 6.0% |
| 28 | $23.87 | 2,650 | $63K | 0.1% |
| 29 | $23.87 | 2,650 | $63K | 0.1% |
| Total | $17.69 avg | 2,393,350 | $42.3M | 100% |
| Filing → |
| TCRR | BUY | 2023-05-10 | $275K | — | Filing → |
| TCRR | BUY | 2023-05-05 | $1.1M | — | Filing → |
| LJPC | SELL | 2021-12-01 | $3.4M | — | Filing → |